Press Releases

Novasep strengthens its management team with the appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites...

Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive committee, while Alain Lamproye joins Novasep...

Adocia reports positive phase II clinical results for the treatment of diabetic foot ulcer

Adocia, a biotechnology company specialized in the development of best-in-class medicines with already approved therapeutic proteins, announces today positive results from its Phase II clinical trial evaluating the safety and efficacy of BioChaperone(R) combined with PDGF-BB for the treatment...

Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess International Conference

Novasep, a leading provider of purification-based manufacturing solutions for lifescience molecules, announces today that Cerenis Therapeutics has been invited by BioProcess International to present its major project CER – 001 ApoA1 - HDL mimetic drug candidate, and describe...

Pharma Rural Marketing India 2012 – India’s most comprehensive conference on pharmaceutical marketing in the rural and semi-urban sector!

India is the world's fourth largest pharmaceutical market in terms of volume and ranks fifteen in terms of value (US$8 billion). In the recent past, pharma companies have seen the growth rate of their rural market sales double with...

According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion to US$74 billion by 2020

According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion to US$74 billion by 2020. All India Organisation of Chemists and Druggists (AIOCD) reported that India's pharmaceutical market grew at 15.7% during December 2011, with...

Immutep and Lonza sign agreement for cell line selection, cell banking and process development of ImmuFact(R) IMP321

Immutep and Lonza announced today an agreement for cell line selection, master cell banking and process development of ImmuFact(R) IMP321. Lonza will initiate the process development for Immutep’s lead product, using Immutep's newly-developed proprietary cell lines. Immutep announced...

Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand

Novasep, a leading supplier of manufacturing solutions to the life sciences industries, today announces the opening of a new 2,000 m2 facility in Shanghai Pudong district, China. The site will boost Novasep's process development and engineering capabilities to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read